Riskpilot← Back to searchSign inGet full accessSleepify AB
ABBankruptOrg 5590958053Wholesale of pharmaceutical and medical goods · NACE 4646Est. 20170 employees
Revenue 2023
SEK 1,6M
-10% vs 2022
EBITDA margin
-86.8%
+35% vs 2022
Equity ratio
3.1%
Financial strength
Net profit 2023
SEK -1,4M
+35% vs 2022
| Revenue | SEK 1,6M | -10% |
| EBITDA | SEK -1,3M | +35% |
| Net profit | SEK -1,4M | +35% |
| Total assets | SEK 2,5M | +35% |
| Equity | SEK 79K | -95% |
| Employees | 0 | — |
Legal name
Sleepify AB
Org number
5590958053
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
3 januari 2017
Share capital
SEK 50 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2023-06-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska bedriva utveckling och försäljning av friskvårdsprodukter samt idka därmed förenlig verksamhet.
Address
Phone
+468884088
Email
info@sleepify.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Revenue | 4 153 | 9 388 | 5 896 | 1 732 | 1 551 |
| Staff expenses | — | — | — | — | −1 324 |
| EBITDA | −1 912 | 1 254 | 1 449 | −2 086 | −1 346 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | — |
| EBIT | −1 912 | 1 254 | 1 449 | −2 086 | −1 346 |
| Net financials | −2 | −5 | 2 | −1 | −10 |
| Profit before tax | −1 914 | 1 249 | 1 450 | −2 087 | −1 356 |
| Tax | −0 | −0 | −143 | −0 | — |
| Net profit | −1 914 | 1 249 | 1 307 | −2 087 | −1 356 |
| Item | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Total assets | 1 999 | 3 991 | 4 232 | 1 855 | 2 499 |
| Equity | 966 | 2 214 | 3 522 | 1 435 | 79 |
| Long-term debt | 0 | 0 | 0 | 0 | — |
| Short-term debt | 1 033 | 1 777 | 710 | 420 | 2 420 |
| Total debt | 1 033 | 1 777 | 710 | 420 | 2 420 |
EBITDA margin
-86.8%
This company
15.8%
Market median
-649% vs market
20192023
Equity ratio
3.1%
This company
38.2%
Market median
-92% vs market
20192023
Return on equity
-1726.9%
This company
18.4%
Market median
-9485% vs market
20192023
Net profit margin
-87.5%
This company
8.1%
Market median
-1180% vs market
20192023
Asset turnover
0.62×
This company
1.12×
Market median
-45% vs market
20192023
Debt / equity
30.82×
This company
0.62×
Market median
-4871% vs market
20192023
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-07-01 – 2021-06-30
- Annual report 2020Filed via Bolagsverket / SCB · Period 2019-07-01 – 2020-06-30
- Annual report 2019Filed via Bolagsverket / SCB · Period 2018-07-01 – 2019-06-30
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
AC Chief Executive Officer | Chief Executive Officer | 2021 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2020 | |
| Deputy Board Member | 2020 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Sleepify AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Anne Cecilia Ullmann | Chief Executive Officer | 0 companies |
| Rasmus Mikael Nilsson | Board of Directors | 0 companies |
| Max Anup Singh Brar | Deputy Board Member | 0 companies |